Media Room


[Industry Voice #8] COVID-19 Vaccine Trial: Volunteers, Challenges, Side Effects

Exlusive interview with Petrovax Pharm Company, responsible for launching a phase III trial for the COVID-19 vaccine developed by CanSino Biologics Inc. This issue features Nikolay Dodonov, the Head of Medical Department at Petrovax Pharm, sharing first-hand insights on the clinical development process for a COVID-19 vaccine trial.



Thank you for your request!
Our team will respond to you within 24 hours.